Our Mission -

We develop improved treatments of life threatening diseases.

Considerable market potential within cancer and coronary infarction treatments.

 
The global market for supportive cancer treatment is more than 10 MUSD and 3.3 million doses of the chemotherapeutic oxaliplatin, which is the foundation in colorectal cancer treatments, are given per year. 1.2 million coronary angioplasties are done each year in connection with acute myocardial
infarction treatment.